Literature DB >> 10678721

Cutaneous lymphocyte-associated antigen expression in children with atopic dermatitis and non-atopic healthy children.

D E Campbell1, A S Kemp.   

Abstract

Cutaneous lymphocyte-associated antigen (CLA) is a cell surface glycoprotein which has been implicated in the homing of lymphocytes to cutaneous sites. It is postulated to play an important role in T-cell migration to skin in atopic dermatitis; however, the expression of CLA in both normal children and children with atopic dermatitis has not been extensively studied. If CLA expression on T cells were important in the traffic of lymphocytes to atopic dermatitis skin lesions, it might be expected that the proportion of CLA+ T cells in unstimulated peripheral blood from children with atopic dermatitis would be elevated. We have examined the proportion of CLA+ T cells in children with atopic dermatitis and non-atopic age-matched controls. The proportion of CLA+ T cells in non-atopic children was highly associated with and increased with increasing age (r = 0.88, p < 0.001). There was no difference between the proportion of T cells expressing CLA in the unstimulated peripheral blood mononuclear cells from children with severe (p = 0.18) or with mild/moderate (p = 0.3) atopic dermatitis and age-matched non-atopic controls. Despite this, children with atopic dermatitis did show evidence of perturbation of CLA expression, as unlike the non-atopic children the proportion of CLA+ T cells in the atopic children did not correlate with age. These findings suggest that while CLA expression may play a role in atopic dermatitis, other as yet undefined surface markers are likely to principally determine the migration of T cells to skin in atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10678721     DOI: 10.1034/j.1399-3038.1999.00042.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  4 in total

1.  Therapeutic effects of recombinant Salmonella typhimurium harboring CCL22 miRNA on atopic dermatitis-like skin in mice.

Authors:  Won Suck Yoon; Seung Seok Lee; Yang Seok Chae; Yong Keun Park
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

2.  Suppression of inflammation by recombinant Salmonella typhimurium harboring CCL22 microRNA.

Authors:  Won Suck Yoon; Seung Rel Ryu; Seung Seok Lee; Yang Seok Chae; Eun Jae Kim; Ji Hyun Choi; Sejin Oh; Se Ho Park; Ji Tae Choung; Young Yoo; Yong Keun Park
Journal:  DNA Cell Biol       Date:  2011-08-08       Impact factor: 3.311

3.  Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis.

Authors:  Christin Wolfram; Claudia Rasche; Heike Audring; Michael Wahls; Margitta Worm
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-03       Impact factor: 2.503

Review 4.  MiRNA in atopic dermatitis.

Authors:  Michał Rożalski; Lidia Rudnicka; Zbigniew Samochocki
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.